XNCR FY 2016 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M+215.3% YoY

Gross Profit

$36M40.7% margin

Operating Income

$23M25.8% margin

Net Income

$24M27.0% margin

EPS (Diluted)

$0.56

Cash Flow

Operating Cash Flow

$95M

Free Cash Flow

$92M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$429M

Total Liabilities

$115M

Stockholders' Equity

$314M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$28M	+215.3%
Gross Profit	$36M	-$6M	+658.9%
Operating Income	$23M	-$18M	+222.9%
Net Income	$24M	-$18M	+234.3%